Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
about
Chromosomal changes in uroepithelial carcinomasMammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerAnalysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesisUnique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissueLadder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridizationChromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladderMutations of cell cycle regulators. Biological and clinical implications for human neoplasia.Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesotheliomaAutophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cellsLoss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetRegulation of SLD5 gene expression by miR-370 during acute growth of cancer cellsMolecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification.Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell linesThe development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma.A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers.Two target regions of allelic loss on chromosome 9 in urinary-bladder cancer.
P2860
Q24811593-E37E4D2D-3C28-4C31-9059-533DEF3EDFD5Q30432032-4A7C1185-4D5D-469D-AD4B-76F6E04E6003Q30433431-E1B1C2CE-2EFF-4529-B3DF-1F4EBAD2E084Q33554443-9EEC7181-BAAF-432C-BB53-33616D99B3CCQ34080289-2BE23D59-D0A6-459E-A588-77531E894B03Q34203924-41F15CC9-178C-4DAE-81C6-87807283BF2AQ34344422-CB94ADB1-6827-4B06-8CB2-A68E9E0A9F76Q34395643-789007D7-8539-407E-A0C2-8B22B46DC4ACQ35754504-9DBC1796-797C-4869-996C-4A845F747EE7Q35782360-33E99B6E-D23C-4ACE-A6EA-52106D7B66ECQ35798342-DA4C372D-7A3D-4F65-94D8-ED545A5C26DEQ36079675-29B2365A-BE60-451E-A945-E2E74EAF345BQ36116080-D45E4B4A-E5D3-493B-B9DB-AEEF00A77EACQ36384361-5CA86FA3-3A52-40D7-A826-6700FBE44741Q36945929-7D08E50C-91C2-4F74-A9B9-05D049BA15FBQ36958930-AC380371-36EB-4FAF-8B10-F4CF14C31816Q37157540-1120FFC1-5D72-4743-B7E1-15DB8AABBCE2Q37770783-602759DF-78D4-40D7-A136-6A61D69DC0E4Q39137809-7D94FE3C-9EDF-46CA-BBE7-EA3918027926Q40499443-EDE064BA-E42C-409E-8A14-A985E8C2604AQ41670639-0433A425-C2D7-4AA1-86BC-2CE29648B11EQ42721217-9B72AB38-C0A4-4C19-9208-856B4A8AF95AQ43201445-08AFBCBD-A46F-4655-A2BC-DDBB563AFF6EQ52629158-83FA6591-93EE-4F79-98BA-4EEDB857F87AQ54936184-9EB0B1F6-5FFA-4435-A0E3-FECDFD6B64A2Q55365458-A1215ABA-E19C-4CF1-AE0A-A7F23855BBE6
P2860
Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@en
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@nl
type
label
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@en
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@nl
prefLabel
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@en
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@nl
P2093
P1433
P1476
Initiation of bladder cancer m ...... ppressor gene on chromosome 9.
@en
P2093
P304
P407
P577
1993-04-01T00:00:00Z